Pozen, Inc. (POZN) Announces Start of Enrollment For PA32540 Phase 3 Program
Friday, November 20, 2009
More...
|
PPD, Inc. (PPDI) to Acquire BioDuro, LLC
Friday, November 20, 2009
More...
|
Big Pharma Seeks to Insulate Itself from Impact of Patent Cliff
Friday, November 20, 2009
More...
|
nContact Surgical, Inc. Results Presented from First Study Reviewing Convergent Approach to Treating Atrial Fibrillation at American Heart Association Scientific Sessions
Thursday, November 19, 2009
More...
|
Precision BioSciences Announces that CELLECTIS SA Loses Patent Protection for Single-Chain Meganucleases in Europe
Thursday, November 19, 2009
More...
|
Cardioxyl Pharmaceuticals Announces Pre-Clinical Results on Lead Clinical Candidate, CXL-1020 at American Heart Association Scientific Sessions 2009
Wednesday, November 18, 2009
More...
|
Aldagen, Inc. (ALDH) Announces Clinical Data for ALD-201 for Ischemic Heart Failure Presented at AHA
Wednesday, November 18, 2009
More...
|
DARA BioSciences, Inc. to Present at the 13th Annual Biotech & Specialty Pharmaceuticals Industry Investor Conference of the New York Society of Security Analysts (“NYSSA”)
Wednesday, November 18, 2009
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Announces Pricing of a Public Offering of Common Stock
Wednesday, November 18, 2009
More...
|
Heart Failure: Thoratec Corporation (THOR)'s 'Temporary' Pumps Could Become A Permanent Treatment, Duke University Medical Center And University of Louisville Study
Wednesday, November 18, 2009
More...
|
|